Maurilio Massara

TL;DR: This study confirms that M SC transplantation into the spinal cord of ALS patients is safe and that MSCs might have a clinical use for future ALS cell based clinical trials.

TL;DR: A safe cell therapy approach that will allow for the treatment of larger pools of patients for later-phase ALS clinical trials, while warranting good reproducibility is described.

TL;DR: The results show that transplantation of hNSC is a safe procedure that causes no major deleterious effects over the short or long term, and the observations support undertaking future phase II clinical studies in which increased cell dosages are studied in larger cohorts of patients.

TL;DR: In this article , a female 84 years old with hypertensive cardiomiopathy and atrial fibrillation on anticoagulation theraphy with Dabigatran was subjected on a pacemaker implantation (29th Sept) for sick sinus syndrome (SSS) after syncope.

TL;DR: In this article , a single-chamber ICD was implanted in primary prevention in the left subclavicular site ( antibiotic prophylaxis with ciprofloxacin 1 g). Chest x-ray showed correct lead placement, no pneumothorax.